Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1123

1.

Vasectomy and Risk of Aggressive Prostate Cancer: A 24-Year Follow-Up Study.

Siddiqui MM, Wilson KM, Epstein MM, Rider JR, Martin NE, Stampfer MJ, Giovannucci EL, Mucci LA.

J Clin Oncol. 2014 Jul 7. pii: JCO.2013.54.8446. [Epub ahead of print]

PMID:
25002716
[PubMed - as supplied by publisher]
2.

Androgen receptor CAG repeat polymorphism and risk of TMPRSS2:ERG positive prostate cancer.

Yoo S, Pettersson A, Jordahl KM, Lis RT, Lindstrom S, Meisner A, Nuttall EJ, Stack EC, Stampfer MJ, Kraft P, Brown M, Loda M, Giovannucci EL, Kantoff PW, Mucci LA.

Cancer Epidemiol Biomarkers Prev. 2014 Jun 12. pii: cebp.0020.2014. [Epub ahead of print]

PMID:
24925673
[PubMed - as supplied by publisher]
3.

Age-related dysfunction in mechanotransduction impairs differentiation of human mammary epithelial progenitors.

Pelissier FA, Garbe JC, Ananthanarayanan B, Miyano M, Lin C, Jokela T, Kumar S, Stampfer MR, Lorens JB, LaBarge MA.

Cell Rep. 2014 Jun 26;7(6):1926-39. doi: 10.1016/j.celrep.2014.05.021. Epub 2014 Jun 5.

PMID:
24910432
[PubMed - in process]
Free Article
4.

5α-Reductase Inhibitors and Risk of High-Grade or Lethal Prostate Cancer.

Preston MA, Wilson KM, Markt SC, Ge R, Morash C, Stampfer MJ, Loda M, Giovannucci E, Mucci LA, Olumi AF.

JAMA Intern Med. 2014 Jun 2. doi: 10.1001/jamainternmed.2014.1600. [Epub ahead of print]

PMID:
24887392
[PubMed - as supplied by publisher]
5.

Body size and multiple myeloma mortality: a pooled analysis of 20 prospective studies.

Teras LR, Kitahara CM, Birmann BM, Hartge PA, Wang SS, Robien K, Patel AV, Adami HO, Weiderpass E, Giles GG, Singh PN, Alavanja M, Beane Freeman LE, Bernstein L, Buring JE, Colditz GA, Fraser GE, Gapstur SM, Michael Gaziano J, Giovannucci E, Hofmann JN, Linet MS, Neta G, Park Y, Peters U, Rosenberg PS, Schairer C, Sesso HD, Stampfer MJ, Visvanathan K, White E, Wolk A, Zeleniuch-Jacquotte A, de González AB, Purdue MP.

Br J Haematol. 2014 May 23. doi: 10.1111/bjh.12935. [Epub ahead of print]

PMID:
24861847
[PubMed - as supplied by publisher]
6.

Genetic variation across C-reactive protein and risk of prostate cancer.

Markt SC, Rider JR, Penney KL, Schumacher FR, Epstein MM, Fall K, Sesso HD, Stampfer MJ, Mucci LA.

Prostate. 2014 Jul;74(10):1034-42. doi: 10.1002/pros.22820. Epub 2014 May 20.

PMID:
24844401
[PubMed - in process]
7.

Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival.

Cao Y, Lindström S, Schumacher F, Stevens VL, Albanes D, Berndt S, Boeing H, Bueno-de-Mesquita HB, Canzian F, Chamosa S, Chanock SJ, Diver WR, Gapstur SM, Gaziano JM, Giovannucci EL, Haiman CA, Henderson B, Johansson M, Le Marchand L, Palli D, Rosner B, Siddiq A, Stampfer M, Stram DO, Tamimi R, Travis RC, Trichopoulos D, Willett WC, Yeager M, Kraft P, Hsing AW, Pollak M, Lin X, Ma J.

J Natl Cancer Inst. 2014 Jun;106(6):dju085.

PMID:
24824313
[PubMed - indexed for MEDLINE]
8.

Sleep duration in midlife and later life in relation to cognition.

Devore EE, Grodstein F, Duffy JF, Stampfer MJ, Czeisler CA, Schernhammer ES.

J Am Geriatr Soc. 2014 Jun;62(6):1073-81. doi: 10.1111/jgs.12790. Epub 2014 May 1.

PMID:
24786726
[PubMed - in process]
9.

Plasma Antioxidants, Genetic Variation in SOD2, CAT, GPX1, GPX4, and Prostate Cancer Survival.

Van Blarigan EL, Ma J, Kenfield SA, Stampfer MJ, Sesso HD, Giovannucci EL, Witte JS, Erdman JW Jr, Chan JM, Penney KL.

Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):1037-46. doi: 10.1158/1055-9965.EPI-13-0670. Epub 2014 Apr 7.

PMID:
24711484
[PubMed - in process]
10.

SPINK1 Protein Expression and Prostate Cancer Progression.

Flavin RJ, Pettersson A, Hendrickson WK, Fiorentino M, Finn SP, Kunz L, Judson G, Lis RT, Bailey D, Fiore C, Nuttall EJ, Martin NE, Stack EC, Penney KL, Rider JR, Sinnott JA, Sweeney CS, Sesso HD, Fall K, Giovannucci EL, Kantoff PW, Stampfer MJ, Loda M, Mucci LA.

Clin Cancer Res. 2014 Mar 31. [Epub ahead of print]

PMID:
24687926
[PubMed - as supplied by publisher]
11.

RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.

Torfadottir JE, Stampfer MJ, Mucci LA, Giovannucci EL.

J Natl Cancer Inst. 2014 Apr;106(4):dju018. doi: 10.1093/jnci/dju018. Epub 2014 Mar 31. No abstract available.

PMID:
24685929
[PubMed - indexed for MEDLINE]
12.

Association of C-peptide and leptin with prostate cancer incidence in the Health Professionals Follow-up Study.

Lai GY, Giovannucci EL, Pollak MN, Peskoe SB, Stampfer MJ, Willett WC, Platz EA.

Cancer Causes Control. 2014 May;25(5):625-32. doi: 10.1007/s10552-014-0369-3. Epub 2014 Mar 25.

PMID:
24664287
[PubMed - in process]
13.

Further evidence that prostate-specific antigen screening reduces prostate cancer mortality.

Stampfer MJ, Jahn JL, Gann PH.

J Natl Cancer Inst. 2014 Mar;106(3):dju026. doi: 10.1093/jnci/dju026. Epub 2014 Mar 7. No abstract available.

PMID:
24610908
[PubMed - in process]
14.

Benchmarks for Operative Outcomes of Robotic and Open Radical Prostatectomy: Results from the Health Professionals Follow-up Study.

Alemozaffar M, Sanda M, Yecies D, Mucci LA, Stampfer MJ, Kenfield SA.

Eur Urol. 2014 Feb 11. pii: S0302-2838(14)00118-3. doi: 10.1016/j.eururo.2014.01.039. [Epub ahead of print]

PMID:
24582327
[PubMed - as supplied by publisher]
15.

Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era.

Zu K, Mucci L, Rosner BA, Clinton SK, Loda M, Stampfer MJ, Giovannucci E.

J Natl Cancer Inst. 2014 Feb;106(2):djt430. doi: 10.1093/jnci/djt430. Epub 2014 Jan 24.

PMID:
24463248
[PubMed - indexed for MEDLINE]
16.

Muscle-strengthening and conditioning activities and risk of type 2 diabetes: a prospective study in two cohorts of US women.

Grøntved A, Pan A, Mekary RA, Stampfer M, Willett WC, Manson JE, Hu FB.

PLoS Med. 2014 Jan;11(1):e1001587. doi: 10.1371/journal.pmed.1001587. Epub 2014 Jan 14.

PMID:
24453948
[PubMed - in process]
Free PMC Article
17.

Involvement of polypyrimidine tract-binding protein (PTBP1) in maintaining breast cancer cell growth and malignant properties.

He X, Arslan AD, Ho TT, Yuan C, Stampfer MR, Beck WT.

Oncogenesis. 2014 Jan 13;3:e84. doi: 10.1038/oncsis.2013.47.

PMID:
24418892
[PubMed]
Free PMC Article
18.

Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.

Shui IM, Lindström S, Kibel AS, Berndt SI, Campa D, Gerke T, Penney KL, Albanes D, Berg C, Bueno-de-Mesquita HB, Chanock S, Crawford ED, Diver WR, Gapstur SM, Gaziano JM, Giles GG, Henderson B, Hoover R, Johansson M, Le Marchand L, Ma J, Navarro C, Overvad K, Schumacher FR, Severi G, Siddiq A, Stampfer M, Stevens VL, Travis RC, Trichopoulos D, Vineis P, Mucci LA, Yeager M, Giovannucci E, Kraft P.

Eur Urol. 2014 Jun;65(6):1069-75. doi: 10.1016/j.eururo.2013.12.058. Epub 2014 Jan 4.

PMID:
24411283
[PubMed - in process]
19.

Reply to M.M.J. Zanders et al.

Penney KL, Stampfer MJ.

J Clin Oncol. 2014 Mar 1;32(7):702-3. doi: 10.1200/JCO.2013.53.8736. Epub 2014 Jan 6. No abstract available.

PMID:
24395854
[PubMed - indexed for MEDLINE]
20.

Variant NKX3.1 and Serum IGF-1: Investigation of Interaction in Prostate Cancer.

Muhlbradt E, Ma J, Severi G, Ortner E, Hayes V, Hoang HN, Stampfer M, Giles G, Pollak M, Gelmann EP.

Genes Cancer. 2013 Nov;4(11-12):535-45. doi: 10.1177/1947601913506009.

PMID:
24386513
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk